Unitary SPCs necessary to attract pharma to UPC/UP system, says Bayer IP chief

Unitary SPCs necessary to attract pharma to UPC/UP system, says Bayer IP chief

Joerg Thomaier also shares his thoughts on the UPC and EPO patent quality in an exclusive IAM interview

Unlock unlimited access to all IAM content